Forge Therapeutics appoints Andrew Tomaras, Ph.D. as Chief Scientific Officer

San Diego, California, June 3, 2021 – Forge Therapeutics, Inc. (Forge), a biotechnology company developing novel anti-infectives targeting bacterial and viral metalloenzymes, ...